PARD (Poniard Pharmaceuticals) Scaled Net Operating Assets: 0.28 (As of Sep. 2011)


What is Poniard Pharmaceuticals Scaled Net Operating Assets?

Poniard Pharmaceuticals PARD Scaled Net Operating Assets is 0.28 as of Sep. 2011.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Poniard Pharmaceuticals's operating assets for the quarter that ended in Sep. 2011 was $5.75 Mil. Poniard Pharmaceuticals's operating liabilities for the quarter that ended in Sep. 2011 was $2.98 Mil. Poniard Pharmaceuticals's Total Assets for the quarter that ended in Jun. 2011 was $9.99 Mil. Therefore, Poniard Pharmaceuticals's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2011 was 0.28.

Poniard Pharmaceuticals Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for Poniard Pharmaceuticals's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poniard Pharmaceuticals Scaled Net Operating Assets Chart

Poniard Pharmaceuticals Annual Data
Trend Dec01 Dec02 Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.70 0.11 0.00 0.01 0.11

Poniard Pharmaceuticals Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.18 0.47 0.35 0.28

PARD vs OBMP, NSPX, ATRX: Scaled Net Operating Assets Comparison

For the Biotechnology subindustry, Poniard Pharmaceuticals's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Poniard Pharmaceuticals Scaled Net Operating Assets vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Poniard Pharmaceuticals's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Poniard Pharmaceuticals's Scaled Net Operating Assets falls into.


Poniard Pharmaceuticals Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Poniard Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2010 is calculated as

Scaled Net Operating Assets (SNOA)(A: Dec. 2010 )
=(Operating Assets (A: Dec. 2010 )-Operating Liabilities (A: Dec. 2010 ))/Total Assets (A: Dec. 2009 )
=(7.313-1.616)/52.442
=0.11

where

Operating Assets(A: Dec. 2010 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=11.643 - 4.33
=7.313

Operating Liabilities(A: Dec. 2010 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=3.19 - 1.574 - 0
=1.616

Poniard Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2011 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Sep. 2011 )
=(Operating Assets (Q: Sep. 2011 )-Operating Liabilities (Q: Sep. 2011 ))/Total Assets (Q: Jun. 2011 )
=(5.752-2.979)/9.989
=0.28

where

Operating Assets(Q: Sep. 2011 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=7.736 - 1.984
=5.752

Operating Liabilities(Q: Sep. 2011 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=4.619 - 1.64 - 0
=2.979

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.28 mean?
Poniard Pharmaceuticals (PARD) has a Scaled Net Operating Assets of 0.28 as of Sep. 2011. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Poniard Pharmaceuticals and its competitors.
Is Poniard Pharmaceuticals' Scaled Net Operating Assets too high?
Poniard Pharmaceuticals' current Scaled Net Operating Assets is 0.28.
How does Poniard Pharmaceuticals' Scaled Net Operating Assets compare to OBMP and NSPX?
Poniard Pharmaceuticals' Scaled Net Operating Assets of 0.28 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Biotechnology company?
A good Scaled Net Operating Assets depends on the Biotechnology industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Poniard Pharmaceuticals and its competitors. Poniard Pharmaceuticals's current Scaled Net Operating Assets is 0.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poniard Pharmaceuticals stock overvalued right now?
Poniard Pharmaceuticals (PARD) has a current Scaled Net Operating Assets of 0.28. The current Scaled Net Operating Assets is 0.28. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Poniard Pharmaceuticals (PARD), the current Scaled Net Operating Assets is 0.28 as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Poniard Pharmaceuticals Business Description

Address 300 Elliott Avenue West, Suite 530, Seattle, CA, USA, 98119
Poniard Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of cancer therapeutics. Its product candidate is picoplatin, a new generation platinum-based cancer therapy.